Robots Theme in Financial Markets
Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA) Annualized Return + 61%
and
Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) Annualized Return + 48%
Theme Robots -- 1 week change +2.91%
$CGNX $IRBT $ISRG $ROK $ZBRA
Theme Description
Robots encompass companies that venture into the creation of robotic technology that serves diverse functions, from lawn maintenance to complex medical procedures for cardiovascular diseases. The rise of automation and robotics is a landmark achievement in contemporary technology. Such advancements have sparked debates regarding its potential impact on the human labor market. A few firms in this sector include Stereotaxis Inc., known for its cardiology instrument navigation systems; Edwards Lifesciences Corp., which offers solutions for late-stage cardiovascular diseases; and iRobot Corp., which produces robots for household chores like mopping.
Key Companies within the Robot Theme
Market Capitalization Insights
The average market capitalization across the robot-themed companies stands at 31.5B. The valuation range for these firms varies widely, with ISRG taking the lead with a hefty valuation of 100.4B and IRBT being on the lower side, valued at 1.1 B.
Price Fluctuations and Noteworthy News
The robot theme observed an average weekly price increase of 2.91%. However, this trend hasn't been uniform throughout, with IRBT recording the highest price jump at 5.79%, and on the flip side, ZBRA registering a decrease of -1.32%.
Other significant news includes:
Volume Analysis
For the theme, the average weekly volume growth was noted at -21.24%. In terms of a longer duration, the monthly and quarterly volume growth averaged at -8.19% and 6.29%, respectively.
Fundamental Analysis Metrics
For a clearer understanding of the robot theme's financial health and potential, a look into their fundamental analysis ratings is essential. The ratings, where a score of 1 is the best and 100 the worst, are:
This analysis provides a holistic view of the robotic theme in the financial market, shedding light on their performance, potential, and position in the broader industry landscape.
The Moving Average Convergence Divergence (MACD) for CGNX turned positive on March 17, 2025. Looking at past instances where CGNX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CGNX's RSI Oscillator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CGNX advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .
CGNX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CGNX as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CGNX entered a downward trend on March 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.766) is normal, around the industry mean (6.031). P/E Ratio (64.231) is within average values for comparable stocks, (64.639). CGNX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.167). Dividend Yield (0.007) settles around the average of (0.022) among similar stocks. P/S Ratio (8.643) is also within normal values, averaging (30.298).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CGNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of robotic technologies used for surgeries
Industry MedicalSpecialties